73898-63-2

Usage

Uses

Used in Fragrance and Flavor Industry:
1-(4-Chloro-3-methoxyphenyl)ethanone is used as a key ingredient in various perfumes and food flavorings for its strong, sweet, floral odor.
Used in Pharmaceutical and Fine Chemicals Synthesis:
1-(4-Chloro-3-methoxyphenyl)ethanone is used as an intermediate in the synthesis of pharmaceuticals and fine chemicals.
Used in Agricultural Industry:
1-(4-Chloro-3-methoxyphenyl)ethanone has potential applications in the agricultural industry.
Used in Cosmetic Industry:
1-(4-Chloro-3-methoxyphenyl)ethanone has potential applications in the cosmetic industry.
It is important to handle this chemical with caution as it can cause irritation to the skin, eyes, and respiratory system if not used properly.

Upstream product

• 342435-00-1 4-chloro-N,3-dimethoxy-N-methylbenzamide 
• 75-16-1 methylmagnesium bromide 
• 85740-98-3 4-chloro-3-methoxybenzoic acid 
• 13726-16-4 4-chloro-3-methoxybenzaldehyde 

Relevant academic research and scientific papers

BETA-HYDROXYETHYLAMINES FOR USE IN THE TREATMENT OR PREVENTION OF NON-ALCOHOLIC FATTY LIVER DISEASES

There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of a non-alcoholic fatty liver disease (NAFLD), such as non-alcoholic steatohepatitis (NASH), wherein X, R1, R2, R3 and n have meanings as provided in the description.

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

COMPOUNDS FOR THE TREATMENT OF HYPERGLYCAEMIA

There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of hyperglycaemia or a disorder characterized by hyperglycaemia, such as type 2 diabetes, wherein X, R1, R2, R3 and n have meanings as provided in the description.

GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.